IDiyas

For the Inventor, By the Inventor

Harleysville, PA, United States of America

Thomas M Connolly

USPTO Granted Patents = 9

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Harleysville, PA (US) (1993 - 1997)
  • Lansdale, PA (US) (2003 - 2005)

Company Filing History:

goldMedal9 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1993-2005

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6838291 - Radioligand and binding assay (2005-01-04),
2. 6544982 - Thrombin receptor antagonists (2003-04-08),
3. 6515023 - Thrombin receptor antagonists (2003-02-04),
4. 5681926 - Thrombin receptor binding peptides (1997-10-28),
5. 5457177 - Thrombin receptor radioligands (1995-10-10),
6. 5340726 - Protein for inhibiting collagen-stimulated platelet aggregation (1994-08-23),
7. 5324715 - Protein for inhibiting collagen-stimulated platelet aggregation (1994-06-28),
8. 5321010 - Proteins for inhibiting adhesion of platelets to collagen (1994-06-14),
9. 5179082 - Method for blocking platelet adhesion to collagen (1993-01-12),

Title: The Innovative Contributions of Thomas M Connolly

Introduction

Thomas M Connolly is a notable inventor based in Harleysville, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work primarily focuses on developing compounds that have potential therapeutic applications.

Latest Patents

One of Connolly's latest patents is related to a radioligand compound, specifically [S]-radiolabeled (+)-N-[1'-(6-cyano-1,2,3,4-tetrahydro-2(R)-naphthalenyl)-3,4-dihydro-4(R)-hydoxyspiro[2H-1-benzopyran-2,4′-piperidin]-6-yl]methanesulfonamide. This invention includes a method for identifying compounds that bind to the I channel, which may have antiarrhythmic activity. Another significant area of his research involves thrombin receptor antagonists.

Career Highlights

Connolly is currently employed at Merck & Company, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the understanding of various therapeutic compounds.

Collaborations

Throughout his career, Connolly has collaborated with esteemed colleagues such as Paul M Keller and Lloyd H Waxman. These partnerships have fostered a collaborative environment that enhances the research and development of new inventions.

Conclusion

Thomas M Connolly's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…